Anti-FCRL4 antibody [EPR21961] (ab239076) is a rabbit monoclonal antibody detecting FCRL4 in IHC-P. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
CD307d, FCRH4, IFGP2, IRTA1, FCRL4, Fc receptor-like protein 4, FcR-like protein 4, FcRL4, Fc receptor homolog 4, IFGP family protein 2, Immune receptor translocation-associated protein 1, FcRH4, hIFGP2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FCRL4 antibody [EPR21961] (AB239076)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling FCRL4 with ab239076 at 1/500 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP) antibody. Cytoplasmic and membranous staining on a subset of lymphocytes in human tonsil (PMID : 12881317) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) ready to use.
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FCRL4 antibody [EPR21961] (AB239076)
Immunohistochemical analysis of paraffin-embedded marginal zone lymphoma tissue labeling FCRL4 with ab239076 at 1/500 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP) antibody. Cytoplasmic and membranous staining on the marginal zone lymphoma cells (PMID : 12881317) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) ready to use.
Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Related conjugates and formulations (2)
-
Anti-FCRL4 antibody [EPR21961] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FCRL4 antibody [EPR21961]
Reactivity data
Product details
What is this antibody validated in?
Anti-FCRL4 antibody [EPR21961] (ab239076) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR21961] also available for your convenience: ab239076, Carrier free - ab239754, Alexa Fluor® 647 - ab320114
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FCRL4 contributes to the regulation of B cell activation and differentiation. FCRL4 has been identified to form complexes with other proteins at the cellular membrane influencing signaling cascades that dampen B cell receptor signaling. This control over signaling pathways is critical for maintaining immune homeostasis and preventing overactive immune responses which can lead to autoimmune conditions. By acting through these complexes FCRL4 helps determine B cell fate during immune responses.
Pathways
FCRL4 is involved in immune regulatory pathways associated with lymphocyte activation. It intersects with the B cell receptor signaling pathway and modulates the interaction between B cell immunological synapse components. FCRL4 interacts with proteins like CD307d within these pathways serving a regulatory role in limiting excessive B cell activation. The control exerted by FCRL4 within these pathways is essential for preventing unnecessary immune activation that could be harmful.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Regenerative biomaterials 12:rbaf089 PubMed41048976
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genome medicine 15:14 PubMed36869384
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical and experimental hematopathology : JCEH 62:195-201 PubMed36436933
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:778329 PubMed34975867
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com